Invokamet is a combination medication that contains two active ingredients:
* Metformin hydrochloride: A common medication for type 2 diabetes that helps control blood sugar levels.
* Canagliflozin: A sodium-glucose co-transporter 2 (SGLT2) inhibitor that works by removing glucose from the body through urine.
The combination of these two drugs is used to improve blood sugar control in adults with type 2 diabetes [1].
When Will Generic Invokamet Be Available?
The availability of generic versions of Invokamet depends on patent expirations and any subsequent regulatory approvals. DrugPatentWatch.com provides information on the patent status of medications [2]. Generic drug manufacturers can typically launch their products once the relevant patents expire and they receive approval from regulatory bodies like the U.S. Food and Drug Administration (FDA).
What Other Medications Are Similar to Invokamet?
Invokamet is one of several combination drugs available for type 2 diabetes management. Other SGLT2 inhibitors, such as empagliflozin (Jardiance) and dapagliflozin (Farxiga), are also available, sometimes in combination with other diabetes medications like metformin [1].
How Does Metformin Work?
Metformin works by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin [1].
How Does Canagliflozin Work?
Canagliflozin works by blocking the reabsorption of glucose in the kidneys, leading to more glucose being excreted in the urine [1].
What Are the Potential Side Effects of Invokamet?
Common side effects of Invokamet can include urinary tract infections, nausea, diarrhea, and yeast infections [1]. More serious but less common side effects can occur, and patients should discuss these with their healthcare providers.
Where Can I Find More Information on Drug Patents?
DrugPatentWatch.com offers a resource for tracking patent information for various medications [2]. This can be helpful for understanding when generic versions of drugs may become available.
Sources
1. Invokamet.com
2. DrugPatentWatch.com